当前位置: 首页 > 期刊 > 《中国实用医药》 > 2012年第27期 > 正文
编号:12325356
单用美蓝检测乳腺癌前哨淋巴结的临床研究(3)
http://www.100md.com 2012年9月25日 韩涛 黄新华
第1页

    参见附件。

     [5]McMasters KM, Wong SL, Martin RC, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy : results of a multlinstitutional study.Ann Surg, 2001, 233 (5)∶676.

    [6]Povoski SP, Dauway EL, Ducatman BS.Sentinel lymph node mapping and biopsy for breast cancer at a rural-based university medical center: initial experience with intraparenchymal and intradermal injection routes.Breast Cancer,2002,9(2):134-144.

    [7]Tuttle TM, Colbert M, Christensen R,et al. Subareolar injection of .99 mTc facilitates sentinel lymph node identification. Ann Surg Oncol, 2002,9(1):77.

    [8]Povoski SP, Olsen JO, Young DC, et al. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann surg 0ncol,2006,13(11):1412-1414.

    [9]Shahar KH, Buchholz TA, Delpassand E, et al. Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma.Cancer,2005,103(7):1323-1329.

    [10]蔚承泽.乳腺癌哨兵淋巴结检测.国外医学肿瘤学分册,2003,30(2):104-106.

您现在查看是摘要介绍页,详见PDF附件(2992kb)